FGF19 and hepatocellular carcinoma: In order to investigate whether the metabolic changes induced by the FGF19-M52 analogue would translate in protection from HCC occurrence, macroscopic analysis of 16 months old Abcb4−/− mice liver was performed at the day of sacrifice.